Macrophage Inflammatory Protein-4 (MIP-4), also known as CCL18, is a chemokine that plays a crucial role in the immune system. Chemokines are small signaling proteins that guide the movement of immune cells to sites of inflammation, infection, and injury. CCL18 is particularly interesting due to its involvement in various immune responses and its potential therapeutic applications.
CCL18 is encoded by the CCL18 gene, which is located on chromosome 17 in humans . The protein consists of 68 amino acids and has a molecular weight of approximately 7.8 kDa . It shares about 61% sequence identity with another chemokine, MIP-1α . The protein contains four highly conserved cysteine residues, which are characteristic of CC chemokines .
CCL18 is primarily expressed in the lungs, lymph nodes, placenta, and bone marrow . It is produced by various cell types, including dendritic cells and macrophages. The protein acts as a chemoattractant, meaning it attracts immune cells to specific locations. Specifically, CCL18 attracts naive T-lymphocytes, CD4+ and CD8+ T-cells, and activated macrophages . This chemotactic activity suggests that CCL18 plays a role in both humoral and cell-mediated immune responses .
CCL18 has been implicated in several diseases and conditions. For instance, elevated levels of CCL18 have been observed in patients with certain types of cancer, chronic inflammatory diseases, and fibrotic disorders. This makes CCL18 a potential biomarker for these conditions and a target for therapeutic interventions.